GL1X · GenesisL1 explorer

MolNFT v1 · #8853 · protein

A second divalent metal ion in the active site of a new crystal form of human APURINIC/APYRIDINIMIC endonuclease, APE1, and its implications for the catalytic mechanism

1HD7 · DNA-(apurinic or apyrimidinic site) lyase: “A second divalent metal ion in the active site of a new crystal form of human APURINIC/APYRIDINIMIC…”. X-ray diffraction, 1 ligand (PB), 3 pockets (best druggability 0.45). MolNFT v1 #8853…

PDB
1HD7
Type
protein
Length
259 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA-(apurinic or apyrimidinic site) lyase
EC
4.2.99.18
UniProt
P27695
Ligands
PB
Pockets
3 · best druggability 0.45

Structure

x-ray diffraction · 1 distinct chain · 31% helix, 26% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADNA-(apurinic or apyrimidinic site) lyase (EC 4.2.99.18)protein25931% helix, 26% strandP27695

Ligands and binding sites

  • PB · Lead (II) ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11820.450.7434PB
2620.340.7715empty
3670.320.7519empty

Compared structures

  • 1HD7 · A Second Divalent Metal Ion in the Active Site of a New Crystal Form of Human… · the same entry in another collection · chain A against A, TM-score 1.00
  • P27695 · AlphaFold monomer V2.0 prediction for DNA-(apurinic or apyrimidinic site) endonuclease… · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.